XML 50 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments and Contingencies - Additional Information (Detail)
€ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Sep. 30, 2016
EUR (€)
Dec. 31, 2015
USD ($)
Aug. 31, 2013
USD ($)
Aug. 31, 2013
EUR (€)
May 31, 2013
USD ($)
Sale Leaseback Transaction [Line Items]                  
Accrued in other current liabilities $ 4,891,000   $ 4,891,000     $ 6,999,000      
Company had royalty and license expenses relating to those agreements 100,000   600,000 $ 500,000          
Current portion of contingent consideration 630,000   630,000     1,286,000      
Contingent consideration non-current portion 4,445,000   4,445,000     4,230,000      
Change in fair value of acquisition contingencies     353,000            
Change in fair value of acquisition contingencies 600,000 $ 0 600,000.0 0          
Research and development milestones [Member]                  
Sale Leaseback Transaction [Line Items]                  
Milestone payments paid 0 300,000 900,000 1,200,000          
BioHelix [Member]                  
Sale Leaseback Transaction [Line Items]                  
Payments for royalties 0 $ 0 200,000 $ 100,000          
Current portion of contingent consideration 600,000   600,000            
Contingent consideration non-current portion 4,100,000   4,100,000            
BioHelix [Member] | Minimum [Member]                  
Sale Leaseback Transaction [Line Items]                  
Contingent consideration                 $ 5,000,000
BioHelix [Member] | Maximum [Member]                  
Sale Leaseback Transaction [Line Items]                  
Contingent consideration                 $ 10,000,000
Andiatec Acquisition [Member]                  
Sale Leaseback Transaction [Line Items]                  
Contingent consideration non-current portion 100,000   100,000            
Andiatec Acquisition [Member] | Research and development milestones [Member]                  
Sale Leaseback Transaction [Line Items]                  
Contingent consideration 3,400,000   3,400,000   € 3.0        
Andiatec Acquisition [Member] | Maximum [Member]                  
Sale Leaseback Transaction [Line Items]                  
Contingent consideration             $ 600,000 € 0.5  
Claims and litigation [Member]                  
Sale Leaseback Transaction [Line Items]                  
Accrued in other current liabilities 0   0     200,000      
Research and Development Agreements [Member]                  
Sale Leaseback Transaction [Line Items]                  
Current commitments $ 2,800,000   $ 2,800,000     $ 4,200,000